Cargando…

Natural Killer receptors distribution in Multiple Sclerosis

Detalles Bibliográficos
Autores principales:	Martinez-Rodriguez, J E, López-Botet, M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007772/ http://dx.doi.org/10.1186/1479-5876-8-S1-P29

Ejemplares similares

Adaptive Features of Natural Killer Cells in Multiple Sclerosis
por: Moreira, Antía, et al.
Publicado: (2019)

Regulation of sepsis-induced IFNγ upon natural killer cell or natural killer T cell depletion in vivo
por: Christaki, E, et al.
Publicado: (2012)

In vivo natural killer and natural killer T-cell depletion affects mortality in a murine pneumococcal pneumonia sepsis model
por: Christaki, E, et al.
Publicado: (2012)

Prognostically relevant natural killer cell-mediated immunoediting in acute myeloid leukemia
por: Chan, Christopher J, et al.
Publicado: (2013)

Natural killer cell status and tolerance in mouse and human bacterial sepsis
por: Souza-Fonseca-Guimaraes, F, et al.
Publicado: (2012)

Enhanced natural killer cell targeting of cancer stem cells using Cetuximab
por: Grossenbacher, Steven K, et al.
Publicado: (2014)

Treatment of solid tumor with autologous natural killer cells in mouse models
por: Liao, Nan-Shih
Publicado: (2014)

Natural Killer (NK) cell responses at female genital mucosa to SIV vaginal challenge
por: Shang, L, et al.
Publicado: (2012)

Natural Killer cells present in gut mucosa as potential ADCC effector cells
por: Sips, M, et al.
Publicado: (2012)

Extensive natural killer cell receptor phenotyping on NK and T cells discloses differences in RA and PsA, potentially mirroring diverse immunoregulatory functions
por: van Bijnen, Sandra TA, et al.
Publicado: (2011)

Epirubicin sequential natural killer cells enhanced the cytotoxicity to breast cancer cells in vitro
por: Song, Yanqiu, et al.
Publicado: (2015)

Bortezomib sensitizes human glioblastoma stem cells to adoptive natural killer cell cytotoxicity
por: Grossenbacher, Steven, et al.
Publicado: (2015)

Headache as a symptom of Multiple Sclerosis
por: Kalamatas, T, et al.
Publicado: (2013)

Killer immunoglobulin-like receptor genes and heterosexual HIV-1 transmission
por: Merino, Aimee, et al.
Publicado: (2010)

Interleukin-21 activates natural killer cell activity against cetuximab-coated pancreatic tumor cells
por: McMichael, Elizabeth L, et al.
Publicado: (2015)

Tumor-derived alpha fetoprotein directly impacts human natural killer cell activity and viability
por: Vujanovic, Lazar, et al.
Publicado: (2015)

Monocyte expression of MICA enhances the Natural Killer Cell response to antibody-coated tumor targets
por: Harper, Amanda, et al.
Publicado: (2014)

Regulatory Functions of Natural Killer Cells in Multiple Sclerosis
por: Gross, Catharina C., et al.
Publicado: (2016)

Natural Killer Cells in Multiple Sclerosis: Entering the Stage
por: Beliën, Jarne, et al.
Publicado: (2022)

P1425: ACTIVATED AND EXPANDED NATURAL KILLER CELLS TRANSDUCED WITH AN NKG2D CHIMERIC ANTIGEN RECEPTOR AGAINST ACUTE MYELOID LEUKEMIA
por: Córdoba, L., et al.
Publicado: (2022)

Inhibition of natural killer (nk) cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome
por: Cifaldi, Loredana, et al.
Publicado: (2014)

Cross-talk between CD8+ T cells and natural killers: the role of mitochondrial Aa2+ transport
por: Uzhachenko, Roman, et al.
Publicado: (2014)

Mechanisms of action of Methylthioadenosine: pathways implicated in neuroprotection in models of Multiple Sclerosis and other neurological diseases
por: Moreno, B, et al.
Publicado: (2010)

KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency
por: Parsons, MS, et al.
Publicado: (2012)

Comparison of Cytotoxic activity and Interferon-g secretion by Natural Killer Cells in HIV-1 and HIV-2 infected individuals
por: Nuvor, Samuel Victor, et al.
Publicado: (2010)

Evaluation of aerosol IL-2 in sarcoma patients with lung metastases for future combination therapy with infused natural killer cells
por: Naing, Aung, et al.
Publicado: (2013)

Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy
por: Zhang, Xiaokui, et al.
Publicado: (2015)

Clinical and imaging approach to headache in patients with multiple sclerosis
por: Voiticovschi-Iosob, C, et al.
Publicado: (2013)

The Role of Natural Killer Cells in Multiple Sclerosis and Their Therapeutic Implications
por: Chanvillard, Coralie, et al.
Publicado: (2013)

Alpha fetoprotein directly induces a unique pro-inflammatory, IL-2 hyperresponsive phenotype in human natural killer cells
por: Vujanovic, Lazar, et al.
Publicado: (2014)

P02.169. The effects of massage therapy on Multiple Sclerosis patients
por: Schroeder, B, et al.
Publicado: (2012)

P019 Obstructive sleep apnoea endotypes in people with multiple sclerosis
por: Carter, S, et al.
Publicado: (2021)

Study of the Helicobacter pylori infection in Iranian patients with multiple sclerosis
por: Sanadgol, N
Publicado: (2010)

Oxidative and nitrative stress as a pathogenic factor in multiple sclerosis
por: Lukáč, Štefan, et al.
Publicado: (2013)

Glatiramer acetate desensitisation in multiple sclerosis patients - the case report
por: Novotna, Bronislava, et al.
Publicado: (2014)

Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control
por: Lundqvist, Andreas, et al.
Publicado: (2015)

Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
por: Bolaños-Mateo, Elixabet, et al.
Publicado: (2014)

Natural killer cells expanded on membrane-bound IL15 or IL21 activate different miRNA transcriptional profiles with functional consequences
por: Somanchi, Anitha, et al.
Publicado: (2015)

P037 Differences in endotypes in people with multiple sclerosis in those with versus without OSA
por: Sloane, J, et al.
Publicado: (2022)

Focus group in Multiple Sclerosis as a tool to increase active patient involvement. A preliminary experience
por: Sgoifo, Annalisa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rafscm1mt3t8ms6isnk1t98q6i